Supplement for Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial

Published: 2 May 2023| Version 1 | DOI: 10.17632/k2bj6fmwhp.1
Contributor:
Jerry Bagel

Description

Supplemental materials for the article entitled, "Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial". Includes Supplemental Tables 1-4 and Supplemental Figures 1-3.

Files

Categories

Dermatology, Psoriasis

Funding

Dermavant Sciences, Inc.

Licence